BioCentury
ARTICLE | Clinical News

Gattex teduglutide regulatory update

December 15, 2014 8:00 AM UTC

Japan granted Orphan Drug designation to teduglutide from NPS to treat short bowel syndrome (SBS). NPS plans to start a Japanese clinical trial of the analog of glucagon-like peptide-2 (GLP-2) by yea...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article